PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-337.65
Negative P/E while Healthcare median is -1.60. Seth Klarman would scrutinize path to profitability versus peers.
608.80
P/S exceeding 1.5x Healthcare median of 10.66. Jim Chanos would check for potential multiple compression risks.
6.17
P/B exceeding 1.5x Healthcare median of 2.97. Jim Chanos would check for potential asset write-down risks.
-105.77
Negative FCF while Healthcare median P/FCF is -5.70. Seth Klarman would investigate cash flow improvement potential.
-1153.38
Negative operating cash flow while Healthcare median P/OCF is -1.48. Seth Klarman would investigate operational improvement potential.
6.17
Fair value ratio exceeding 1.5x Healthcare median of 2.98. Jim Chanos would check for valuation bubble risks.
-0.07%
Negative earnings while Healthcare median yield is -0.67%. Seth Klarman would investigate path to profitability.
-0.95%
Negative FCF while Healthcare median yield is -0.20%. Seth Klarman would investigate cash flow improvement potential.